Drug Approval | July 13, 2025
Moderna receives USFDA approval for Covid-19 vaccine ‘Spikevax’
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
A triple-action Formula for comprehensive respiratory relief
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
If approved, linerixibat could address high unmet medical need of patients living with cholestatic pruritus (relentless itch) and related sleep interference
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Usnoflast has previously also received ‘Orphan Drug Designation (ODD)’ from the USFDA
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
Subscribe To Our Newsletter & Stay Updated
